The price of United Continental Holdings, Inc. (NASDAQ:UAL) went up by $1.09 now trading at $93.03. Their shares witnessed a 53.92% increase from the 52-week low price of $60.44 they recorded on 2018-02-09. Even though it is still -5.18% behind the $97.85 high touched on 2018-12-03. The last few days have been rough for the stock, as its price has decreased by -1.53% during the week. It has also performed better over the past three months, as it added around 6.77% while it has so far climbed around 49.57% during the course of a year. The stock of UAL recorded 38.03% uptrend from the beginning of this year till date. The 12-month potential price target for United Continental Holdings, Inc. is set at $102.53. This target means that the stock has an upside potential to increase by 10.21% from the current trading price.
When giving their opinion, around 52.63% of Wall Street analysts, which represents 10 out of 19 rated the stock as a Buy. 9 brokerage firms of the remaining 47.37% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate UAL shares held by institutional investors represents 99.6% of total shares. 94 institutions entered new United Continental Holdings, Inc. (NASDAQ:UAL) positions, 247 added to their existing positions in these shares, 303 lowered their positions, and 61 exited their positions entirely.
United Continental Holdings, Inc. (UAL) trade volume has increased by 0.48% as around 3,750,409 shares were sold when compared with its 50-day average volume of traded shares which is 3,732,672. At the moment, UAL is witnessing a uptrend, as it is trading 0.15% above its 20-day SMA, 5.09% above its 50-day SMA, and 19.44% above its 200-day SMA. The company runs an ROE of roughly 25.6%, with financial analysts predicting that their earnings per share growth will be around 18.7% per annum for the next five year. This will be compared to the 37.6% increase witnessed over the past five years.
The first technical resistance point for United Continental Holdings, Inc. (NASDAQ:UAL) will likely come at $94.12, marking a 1.16% premium to the current level. The second resistance point is at $95.2, about 2.28% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $89.08, the lower end of the range. UAL’s 14-day MACD is 0.34 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 53.45, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 27.76 percent, which is low when compared to that of the 50-day’s 31.93 percent.
The shares of Cigna Corporation (NYSE:CI) has decreased by -1.63%, and now trading at $214.29 on the Wall Street in the intra-day deal, with their shares traded now around 2,840,217. This is a rise of 482,269 shares over the average 2,357,948 shares that were traded daily over the last three months. The stock that is trading at $214.29 went higher by 31.45% from its 52-week low of $163.02 that it attained back on 2018-03-13. The stock recorded a 52-week high of $227.13 nearly 312 days ago on 2018-01-29.
CI stock hasn’t performed well over the past 30 days, as it lost -0.56% while its price climbed by 5.51% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -3.35% over the last week. The stock’s 12-month potential target price is now at $244.32. This means that the stock price might likely increase by 14.01% from its current trading price.17 out of 21 Wall Street analysts which represents 80.95% rated the stock as a buy while the remaining 19.05 rated it as a hold, with 0 of analysts rating it as a sell.
Cigna Corporation (NYSE:CI) has been utilizing an ROE that is roughly 19%, with stock analysts predicting that the company’s EPS for the next five years will go up by 14.74% per year, following the 11.5% raise that was witnessed during the past five years. The stock at the moment is on a downtrend, trading -0.91% below its 20-day SMA, 0.89% above its 50-day SMA, and 14.68% above its 200-day SMA. In percentage terms, the aggregate Cigna Corporation shares held by institutional investors is 96.6%. 108 institutions jumped in to acquire Cigna Corporation (CI) fresh stake, 374 added to their current holdings in these shares, 416 lowered their positions, and 91 left no stake in the company.
The stock’s 9-day MACD is 0.23 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 44.48, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 23.16 percent, which is less when compared to that of the 50-day’s 25.52 percent. On the daily chart, we see that the stock could reach the first level of resistance at $218.51, sporting a 1.93% premium to the current level. The next resistance point is at $222.73, representing nearly 3.79% premium to the current market price of Cigna Corporation (CI). On the other hand, failure to breach the immediate hurdles can drag it down to $202.39, the lower end of the range.